Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Indoco Remedies gets USFDA EIR for Patalganga facility

Indoco Remedies arm commences commercial production of oral care products

Ruchika Sharma4 March 2024 11:51 AM IST

Mumbai: Warren Remedies Private Limited, a Wholly Owned Subsidiary of Indoco Remedies Limited has commenced its commercial production on March...

GSK CEO Emma Walmsley total remuneration rises 51 percent to USD 16 million in 2023

Ruchika Sharma4 March 2024 10:00 AM IST

London: GSK CEO Emma Walmsley's total remuneration rose 51 per cent to 12.7 million pounds ($16 million) in 2023, thanks to a big jump in...

USFDA Approves Bionpharmas Generic HIV Drug Etravirine

Boston Scientific secures USFDA okay for AGENT Drug-Coated Balloon to treat coronary in-stent restenosis

Ruchika Sharma3 March 2024 4:00 PM IST

Marlborough: Boston Scientific Corporation has announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT...

NPPA Finally Allows GSK to Discontinue Grisovin FP

Heartburn drug: GSK settles another lawsuit on Zantac in California

Ruchika Sharma3 March 2024 2:00 PM IST

The USFDA in 2020 pulled all brands named Zantac and generic versions of the drug off the market, triggering a wave of lawsuits.

Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans Appeal

RSV vaccine Abrysvo is protective through a second year: Pfizer

Ruchika Sharma3 March 2024 12:00 PM IST

New York: Pfizer has said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its ability to protect against the...

AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter Market

AbbVie, OSE Immunotherapeutics collaborate to develop novel monoclonal antibody for Chronic Inflammation

Ruchika Sharma3 March 2024 10:00 AM IST

Under the terms of the agreement, AbbVie will receive an exclusive global license to develop, manufacture and commercialize OSE-230.

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic inaugurates RnD center outside US in Hyderabad

Ruchika Sharma2 March 2024 3:23 PM IST

Hyderabad: Medtronic, an American medical technology company has inaugurated its newly expanded state-of-the-art Medtronic Engineering and...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

Johnson and Johnson gets USFDA approval for Rybrevant, chemotherapy combo for lung cancer treatment

Ruchika Sharma2 March 2024 2:33 PM IST

Raritan: Johnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...

Maha: Rs 14-Crore Mephedrone Unit Busted Near Police Station, Cop Suspended for Negligence

Consignment of spurious drugs worth Rs 43 lakh seized, 2 held

Ruchika Sharma2 March 2024 1:58 PM IST

Telangana Police, along with the local police and Crime Intelligence Unit, raided a pharma company named Nectar Herbs and Drugs located in Sidcul,...

USFDA concludes inspection at Cipla Qidong facility with zero observations

Ruchika Sharma2 March 2024 12:29 PM IST

Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has concluded a pre-approval inspection with zero Form 483...

Aurobindo Pharma Extends Timeline to Acquire 26% in Swarnaakshu Solar

Aurobindo Pharma bags USFDA nod for Fingolimod Capsules for multiple sclerosis

Ruchika Sharma2 March 2024 11:32 AM IST

Fingolimod Capsules, 0.5 mg, is indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical...

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

USFDA closes inspection at Shilpa Medicare Hyderabad lab

Ruchika Sharma1 March 2024 4:52 PM IST

Karnataka: Shilpa Medicare has announced that the United States Food and Drug Administration (USFDA) has closed the inspection at the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok